Anna Naito
Overview
Explore the profile of Anna Naito including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
306
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Oas H, Cook L, Schwantes-An T, Walsh L, Wills A, Mata I, et al.
NPJ Parkinsons Dis
. 2024 Oct;
10(1):202.
PMID: 39455611
Genetic testing for Parkinson's disease (PD) is infrequently performed due to perceptions of low utility. We investigated the personal utility in PD GENEration and how results lead to enrollment in...
2.
Cook L, Verbrugge J, Schwantes-An T, Schulze J, Foroud T, Hall A, et al.
Brain
. 2024 Jul;
147(8):2668-2679.
PMID: 39074992
Variants in seven genes (LRRK2, GBA1, PRKN, SNCA, PINK1, PARK7 and VPS35) have been formally adjudicated as causal contributors to Parkinson's disease; however, individuals with Parkinson's disease are often unaware...
3.
Marras C, Meyer Z, Liu H, Luo S, Mantri S, Allen A, et al.
Mov Disord Clin Pract
. 2024 Jul;
11(10):1212-1222.
PMID: 39030949
Background: Depression is common in Parkinson's disease (PD) but is underrecognized clinically. Although systematic screening is a recommended strategy to improve depression recognition in primary care practice, it has not...
4.
Cook L, Verbrugge J, Schwantes-An T, Schulze J, Beck J, Naito A, et al.
Genet Med
. 2023 Jun;
25(10):100907.
PMID: 37302021
Purpose: To evaluate the feasibility and impact of offering genetic testing and counseling to patients with Parkinson's disease (PD), with the potential to enroll in gene-targeted clinical trials and improve...
5.
Rao S, Li Y, Lapin B, Pattipati S, Galvelis K, Naito A, et al.
NPJ Parkinsons Dis
. 2023 Jun;
9(1):86.
PMID: 37277346
Parkinson's disease (PD) is an age-related neurological disorder known for the observational differences in its risk, progression, and severity between men and women. While estrogen has been considered to be...
6.
Di Luca D, Luo S, Liu H, Cohn M, Davis T, Ramirez-Zamora A, et al.
Neurology
. 2023 Apr;
100(21):e2170-e2181.
PMID: 37019661
Background And Objectives: Racial and ethnic minorities have been underrepresented in Parkinson disease (PD) research, limiting our understanding of treatments and outcomes across all non-White groups. The goal of this...
7.
Soto M, Fernandez M, Bravo P, Lahoz S, Garrido A, Sanchez-Rodriguez A, et al.
NPJ Parkinsons Dis
. 2023 Feb;
9(1):15.
PMID: 36732514
The LRRK2 G2019S pathogenic mutation causes LRRK2-associated Parkinson's disease (L2PD) with incomplete penetrance. LRRK2 non-manifesting carriers (L2NMC) are at PD high risk but predicting pheno-conversion is challenging given the lack...
8.
Patterson C, Joslin E, Gil A, Spigle W, Nemet T, Chahine L, et al.
Trials
. 2022 Oct;
23(1):855.
PMID: 36203214
Background: To date, no medication has slowed the progression of Parkinson's disease (PD). Preclinical, epidemiological, and experimental data on humans all support many benefits of endurance exercise among persons with...
9.
Rao S, Pattipati S, Salim A, Gutierrez N, Naito A, Ghosh K, et al.
Mov Disord
. 2022 May;
37(5):1112-1113.
PMID: 35587626
No abstract available.
10.
Cook L, Schulze J, Verbrugge J, Beck J, Marder K, Saunders-Pullman R, et al.
Parkinsonism Relat Disord
. 2021 Oct;
92:107-111.
PMID: 34696975
Introduction: There have been no specific guidelines regarding which genes should be tested in the clinical setting for Parkinson's disease (PD) or parkinsonism. We evaluated the types of clinical genetic...